Cargando…

TMS-EEG indexes abnormal GABAergic signalling in patients with schizophrenia

AIMS: Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation tool designed to probe the strength of inhibitory and excitatory neurotransmission in the cortex. Combined with electromyography, paired-pulse TMS paradigms have revealed a deficit in inhibition mediated by GABA-A rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Shergill, Sukhwinder S, Santoro, Viviana, Rocchi, Lorenzo, Hou, Meng Di, Premoli, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771355/
http://dx.doi.org/10.1192/bjo.2021.185
_version_ 1784635585247313920
author Shergill, Sukhwinder S
Santoro, Viviana
Rocchi, Lorenzo
Hou, Meng Di
Premoli, Isabella
author_facet Shergill, Sukhwinder S
Santoro, Viviana
Rocchi, Lorenzo
Hou, Meng Di
Premoli, Isabella
author_sort Shergill, Sukhwinder S
collection PubMed
description AIMS: Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation tool designed to probe the strength of inhibitory and excitatory neurotransmission in the cortex. Combined with electromyography, paired-pulse TMS paradigms have revealed a deficit in inhibition mediated by GABA-A receptors in patients with schizophrenia. Combined TMS-electroencephalography (TMS-EEG) provides a more detailed examination of cortical excitability and may shed more light into the pathophysiology of schizophrenia. Of the various peaks of the TMS-evoked EEG signal, responses at 45 (N45) and 100 ms (N100) likely reflect GABA-A and GABA-B receptor-mediated inhibition, respectively. Responses at 25 ms (P25) are affected by voltage-gated channel ligands, whereas glutamatergic processes may be related to the P70 component. We here aim to systematically investigate the role of these neural processes in patients with schizophrenia by using TMS-EEG. METHOD: TMS-evoked EEG potentials (TEPs) were recorded in patients with schizophrenia (n = 19) and in age-matched healthy controls (n = 17). 150 TMS pulses at 90% of resting motor threshold were applied over the left primary motor cortex during EEG recording. Differences in TEPs between the two groups were analysed for all electrodes and for time windows corresponding to each TEP (P25: 0.015-0.035 ms; N45: 0.035-0.06 ms; P70: 0.035-0.06 ms; N100: 0.09-0.14ms) by applying multiple independent sample t-tests. Further, a cluster-based permutation analysis approach was implemented to correct for multiple comparisons. RESULT: Compared to controls, patients showed amplitude reduction for the P25 (negative and positive cluster; p < 0.001 and p = 0.04, respectively), N45 (negative and positive cluster; p < 0.001 and p = 0.001, respectively) and P70 component (negative and positive cluster; p = 0.04 and p = 0.004, respectively). CONCLUSION: There results extend on previous literature about impairment of GABA-A receptor mediated inhibition in schizophrenia, as demonstrated by the N45 amplitude reduction, whereas no significant differences in GABA-B index (i.e., N100) were revealed. Our results also showed that, although specific mechanisms underlying P25 and P70 have not been fully elucidated yet, excitatory neurotransmission is altered in this clinical population. To conclude, TMS-EEG may provide a more comprehensive view of the inhibitory and excitatory mechanisms involved in the pathophysiology of schizophrenia.
format Online
Article
Text
id pubmed-8771355
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-87713552022-01-31 TMS-EEG indexes abnormal GABAergic signalling in patients with schizophrenia Shergill, Sukhwinder S Santoro, Viviana Rocchi, Lorenzo Hou, Meng Di Premoli, Isabella BJPsych Open Rapid-Fire Poster Presentations AIMS: Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation tool designed to probe the strength of inhibitory and excitatory neurotransmission in the cortex. Combined with electromyography, paired-pulse TMS paradigms have revealed a deficit in inhibition mediated by GABA-A receptors in patients with schizophrenia. Combined TMS-electroencephalography (TMS-EEG) provides a more detailed examination of cortical excitability and may shed more light into the pathophysiology of schizophrenia. Of the various peaks of the TMS-evoked EEG signal, responses at 45 (N45) and 100 ms (N100) likely reflect GABA-A and GABA-B receptor-mediated inhibition, respectively. Responses at 25 ms (P25) are affected by voltage-gated channel ligands, whereas glutamatergic processes may be related to the P70 component. We here aim to systematically investigate the role of these neural processes in patients with schizophrenia by using TMS-EEG. METHOD: TMS-evoked EEG potentials (TEPs) were recorded in patients with schizophrenia (n = 19) and in age-matched healthy controls (n = 17). 150 TMS pulses at 90% of resting motor threshold were applied over the left primary motor cortex during EEG recording. Differences in TEPs between the two groups were analysed for all electrodes and for time windows corresponding to each TEP (P25: 0.015-0.035 ms; N45: 0.035-0.06 ms; P70: 0.035-0.06 ms; N100: 0.09-0.14ms) by applying multiple independent sample t-tests. Further, a cluster-based permutation analysis approach was implemented to correct for multiple comparisons. RESULT: Compared to controls, patients showed amplitude reduction for the P25 (negative and positive cluster; p < 0.001 and p = 0.04, respectively), N45 (negative and positive cluster; p < 0.001 and p = 0.001, respectively) and P70 component (negative and positive cluster; p = 0.04 and p = 0.004, respectively). CONCLUSION: There results extend on previous literature about impairment of GABA-A receptor mediated inhibition in schizophrenia, as demonstrated by the N45 amplitude reduction, whereas no significant differences in GABA-B index (i.e., N100) were revealed. Our results also showed that, although specific mechanisms underlying P25 and P70 have not been fully elucidated yet, excitatory neurotransmission is altered in this clinical population. To conclude, TMS-EEG may provide a more comprehensive view of the inhibitory and excitatory mechanisms involved in the pathophysiology of schizophrenia. Cambridge University Press 2021-06-18 /pmc/articles/PMC8771355/ http://dx.doi.org/10.1192/bjo.2021.185 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Rapid-Fire Poster Presentations
Shergill, Sukhwinder S
Santoro, Viviana
Rocchi, Lorenzo
Hou, Meng Di
Premoli, Isabella
TMS-EEG indexes abnormal GABAergic signalling in patients with schizophrenia
title TMS-EEG indexes abnormal GABAergic signalling in patients with schizophrenia
title_full TMS-EEG indexes abnormal GABAergic signalling in patients with schizophrenia
title_fullStr TMS-EEG indexes abnormal GABAergic signalling in patients with schizophrenia
title_full_unstemmed TMS-EEG indexes abnormal GABAergic signalling in patients with schizophrenia
title_short TMS-EEG indexes abnormal GABAergic signalling in patients with schizophrenia
title_sort tms-eeg indexes abnormal gabaergic signalling in patients with schizophrenia
topic Rapid-Fire Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771355/
http://dx.doi.org/10.1192/bjo.2021.185
work_keys_str_mv AT shergillsukhwinders tmseegindexesabnormalgabaergicsignallinginpatientswithschizophrenia
AT santoroviviana tmseegindexesabnormalgabaergicsignallinginpatientswithschizophrenia
AT rocchilorenzo tmseegindexesabnormalgabaergicsignallinginpatientswithschizophrenia
AT houmengdi tmseegindexesabnormalgabaergicsignallinginpatientswithschizophrenia
AT premoliisabella tmseegindexesabnormalgabaergicsignallinginpatientswithschizophrenia